BLOOD TESTING SYSTEM AND METHOD

(19)

(11)

EP 3 001 196 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	31.10.2018 Bulletin 2018/44

(45)	Mention of the grant of the patent:
	12.09.2018 Bulletin 2018/37

(21)	Application number: 15187347.8

(22)	Date of filing: 29.09.2015

(51)

International Patent Classification (IPC):

G01N 33/49^(2006.01)

G01N 33/86^(2006.01)

(54)	BLOOD TESTING SYSTEM AND METHOD BLUTTESTSYSTEM UND VERFAHREN SYSTÈME ET PROCÉDÉ DE TEST DE SANG

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

29.09.2014 US 201414500248

(43)	Date of publication of application:
	30.03.2016 Bulletin 2016/13

(60)	Divisional application:
	18193752.5

(73)	Proprietor: C A Casyso GmbH
	4052 Basel (CH)

(72)	Inventors:
	McCLUSKEY, Cory Lee Encinitas, CA 92024 (US) HILLMAN, Robert S. San Diego, CA 92130 (US) GORIN, Michael Incline Village, NV 89450 (US) SCHWAIGER, Hubert Martin 81667 München (DE)

(74)	Representative: Isarpatent
	Patent- und Rechtsanwälte Behnisch Barth Charles Hassa Peckmann & Partner mbB Friedrichstrasse 31 80801 München 80801 München (DE)

(56)

References cited: :

WO-A1-02/50535
WO-A1-2014/115478
US-A- 4 599 219
US-A1- 2010 154 520
US-B1- 6 750 053

WO-A1-2014/103744
DE-U1-202014 002 289
US-A1- 2008 160 500
US-A1- 2014 004 613
US-B2- 7 422 905

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).